單核苷酸多態性 (SNP)基因型鑒定：技術與全球市場

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

出版日期: 2024年07月16日 | 出版商:

BCC Research | 英文 110 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球單核苷酸多態性 (SNP)基因型鑒定市場規模預計將從 2024 年的320 億美元增加到 2029 年底的 855 億美元，預測期內複合年成長率為 21.7%。

北美地區預計將從 2024 年的 138 億美元成長到 2029年終的370 億美元，複合年成長率為 21.9%。此外，歐洲地區預計將從 2024 年的 830 萬美元成長到 2029年終的217 億美元，複合年成長率為 21.2%。

該報告調查了全球單核苷酸多態性（SNP）基因型鑒定市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測以及各種細分。

市場趨勢
細分細分
全球 SNP基因型鑒定市場：依技術分類
微陣列和基因晶片
SNP定序
TaqMan Allelic Discrimination
Applied Biosystems SNPlex Platform
MassArray Maldi-TOF
其他
全球 SNP基因型鑒定市場：依應用分類
藥物和藥物基因組學
診斷研究
農業生物技術
動物遺傳學
植物改良
水產養殖
其他
地域分佈
全球 SNP基因型鑒定市場：按地區
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

資金籌措
主要企業
主要企業採取的關鍵策略
合夥
其他策略

第 7 章 SNP基因型鑒定市場的永續性：ESG 視角

市場ESG表現
SNP基因型鑒定產業的 ESG 實踐
環保性能
社會表現
管治績效
ESG風險評估
BCC的結語

第8章附錄

調查方法
縮寫詞
參考
公司簡介
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
CYTIVA
ENZO BIOCHEM INC.
EPIGENDX
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO139B

The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.

The North American SNP market is expected to grow from $13.8 billion in 2024 and is projected to reach $37.0 billion by the end of 2029, at a CAGR of 21.9% during the forecast period of 2024 to 2029.

The European SNP market is expected to grow from $8.3 million in 2024 and is projected to reach $21.7 billion by the end of 2029, at a CAGR of 21.2% during the forecast period of 2024 to 2029.

Report Scope:

This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes:

37 data tables and 44 additional tables
An overview of the global market for single nucleotide polymorphism (SNP) genotyping
Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom's MassArray DNA analysis platform, Bruker's MALDI-TOF array, SNP pyrosequencing, microarrays and gene chips, and Applied Biosystems' (now part of Thermo Fisher Scientific) SNPlex and TaqMan
Analysis of the regulatory framework and policies affecting the industry
Discussion of the ESG practices of, as well as challenges for, companies
Analysis of the key companies' market shares and their proprietary technologies, strategic alliances and patents
Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
SNP for Mutational Analysis
SNP Definition
Methods of Studying SNPs
Classification of SNPs
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Declining Prices of DNA Sequencing Methods
Demand for Personalized Treatments
Personalized Medicine and SNP Genotyping in the Drug Development Process
Increasing Demand for Genome Analysis in Plants and Animal Livestock
Market Restraints
Reimbursement Policies
Market Opportunities
Increasing Applications of SNP Genotyping
Rising Investments in Genomics Research

Chapter 4 Emerging Technologies and Developments

SNP-Chip
SNP Genotyping Technologies in Forensic Science
Artificial Intelligence in SNP Genotyping

Chapter 5 Market Segmentation Analysis

Market Trends
Segmentation Breakdown
Global Market for SNP Genotyping, by Technology
Microarrays and GeneChips
SNP Pyrosequencing
TaqMan Allelic Discrimination
Applied Biosystems SNPlex Platform
MassArray Maldi-TOF
Other SNP Genotyping Technologies
Global Market for SNP Genotyping, by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Animal Genetics
Plant Improvements
Aquaculture
Other Applications
Geographic Breakdown
Global Market for SNP Genotyping, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Funding
Leading Companies
Key Strategies Adopted by Players
Partnerships
Other Strategies

Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective

ESG Performance in the Market
ESG Practices in the SNP Genotyping Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
CYTIVA
ENZO BIOCHEM INC.
EPIGENDX
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for SNP Genotyping, by Region, Through 2029
Table 1 : SNP Public Databases
Table 2 : Role of SNP Genotyping in Stages of the Drug Development Process
Table 3 : Global Market for SNP Genotyping, by Technology, Through 2029
Table 4 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, Through 2029
Table 5 : Global Market for Pyrosequencing in SNP Genotyping, by Region, Through 2029
Table 6 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, Through 2029
Table 7 : Global Market for Applied Biosystems SNPlex Platform in SNP Genotyping, by Region, Through 2029
Table 8 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, Through 2029
Table 9 : Global Market for Other Technologies in SNP Genotyping, by Region, Through 2029
Table 10 : Global Market for SNP Genotyping, by Application, Through 2029
Table 11 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, Through 2029
Table 12 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, Through 2029
Table 13 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, Through 2029
Table 14 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, Through 2029
Table 15 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, Through 2029
Table 16 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, Through 2029
Table 17 : Global Market for Other Applications in SNP Genotyping, by Region, Through 2029
Table 18 : Global Market for SNP Genotyping, by Region, Through 2029
Table 19 : North American Market for SNP Genotyping, by Technology, Through 2029
Table 20 : North American Market for SNP Genotyping, by Application, Through 2029
Table 21 : National Genome Projects in Europe
Table 22 : European Market for SNP Genotyping, by Technology, Through 2029
Table 23 : European Market for SNP Genotyping, by Application, Through 2029
Table 24 : Asia-Pacific Market for SNP Genotyping, by Technology, Through 2029
Table 25 : Asia-Pacific Market for SNP Genotyping, by Application, Through 2029
Table 26 : RoW Market for SNP Genotyping, by Technology, Through 2029
Table 27 : RoW Market for SNP Genotyping, by Application, Through 2029
Table 28 : Major Private and Public Funding Organizations
Table 29 : National Human Genome Research Institute, NIH Funded and Completed Projects
Table 30 : Leaders in the SNP Genotyping Market, 2023
Table 31 : Business Expansions in the Global SNP Genotyping Market, 2021-2024
Table 32 : Product Launches in the Global SNP Genotyping Market, 2021-2024
Table 33 : Collaborations and Agreements in the Global SNP Genotyping Market, 2022 and 2023
Table 34 : Partnerships in the Global SNP Genotyping Market, 2021-2024
Table 35 : Other Business Strategies Adopted by Key Players in SNP Genotyping Market, 2021-2024
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : Environmental Performance Initiatives in the SNP Genotyping Market
Table 38 : Social Performance Initiatives in the SNP Genotyping Market
Table 39 : Governance Performance Initiatives in the SNP Genotyping Market
Table 40 : ESG Rankings for SNP Genotyping Companies, 2023*
Table 41 : Abbreviations Used in This Report
Table 42 : Agilent Technologies Inc.: Company Snapshot
Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Agilent Technologies Inc.: Product Portfolio
Table 45 : Agilent Technologies Inc.: News/Key Developments, 2021-2023
Table 46 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 47 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 48 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2021-2023
Table 49 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 50 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 51 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 52 : Cytiva: Company Snapshot
Table 53 : Cytiva: Product Portfolio
Table 54 : Cytiva: News/Key Developments, 2023
Table 55 : Enzo Biochem Inc.: Company Snapshot
Table 56 : Enzo Biochem Inc.: Financial Performance, FY 2022 and 2023
Table 57 : Enzo Biochem Inc.: Product Portfolio
Table 58 : Enzo Biochem Inc.: News/Key Developments, 2022
Table 59 : EpigenDx.: Company Snapshot
Table 60 : EpigenDx: Service Portfolio
Table 61 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 62 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 63 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 64 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021
Table 65 : Illumina Inc.: Company Snapshot
Table 66 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 67 : Illumina Inc.: Services Portfolio
Table 68 : Illumina Inc.: News/Key Developments, 2022 and 2023
Table 69 : Qiagen: Company Snapshot
Table 70 : Qiagen: Financial Performance, FY 2022 and 2023
Table 71 : Qiagen: Product Portfolio
Table 72 : Qiagen: News/Key Developments, 2023 and 2024
Table 73 : Standard BioTools: Company Snapshot
Table 74 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 75 : Standard BioTools: Product Portfolio
Table 76 : Standard BioTools: News/Key Developments, 2022 and 2023
Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 80 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

Summary Figure : Global Market for SNP Genotyping, by Region, 2021-2029
Figure 1 : Classification of SNPs
Figure 2 : PESTEL Analysis: SNP Genotyping Market
Figure 3 : Market Dynamics of SNP Genotyping
Figure 4 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
Figure 5 : Snapshot of SNP Genotyping Market: Business Strategies
Figure 6 : Global Market Share for SNP Genotyping, by Technology, 2024
Figure 7 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, 2021-2029
Figure 8 : Global Market for Pyrosequencing in SNP Genotyping, by Region, 2021-2029
Figure 9 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, 2021-2029
Figure 10 : Global Market for Applied Biosystems SNPlex in SNP Genotyping, by Region, 2021-2029
Figure 11 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, 2021-2029
Figure 12 : Global Market for Other Technologies in SNP Genotyping, by Region, 2021-2029
Figure 13 : Global Market Share for SNP Genotyping, by Application, 2024
Figure 14 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, 2021-2029
Figure 15 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, 2021-2029
Figure 16 : Major Applications of SNP Genotyping in Agricultural Biotechnology
Figure 17 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, 2021-2029
Figure 18 : Applications of SNP Genotyping in Animal Genetics
Figure 19 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, 2021-2029
Figure 20 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, 2021-2029
Figure 21 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, 2021-2029
Figure 22 : Global Market for Other Applications in SNP Genotyping, by Region, 2021-2029
Figure 23 : Global Market Share for SNP Genotyping, by Region, 2024
Figure 24 : Share of New Genetic Tests in the U.S., by CLIA-certified Laboratory, 2012 to 2022
Figure 25 : North American Market for SNP Genotyping, by Technology, 2021-2029
Figure 26 : North American Market for SNP Genotyping, by Application, 2021-2029
Figure 27 : European Market for SNP Genotyping, by Technology, 2021-2029
Figure 28 : European Market for SNP Genotyping, by Application, 2021-2029
Figure 29 : Drivers of the Asia-Pacific Market for SNP Genotyping
Figure 30 : Asia-Pacific Market for SNP Genotyping, by Technology, 2021-2029
Figure 31 : Asia-Pacific Market for SNP Genotyping, by Application, 2021-2029
Figure 32 : RoW Market for SNP Genotyping, by Technology, 2021-2029
Figure 33 : RoW Market for SNP Genotyping, by Application, 2021-2029
Figure 34 : Share of the Global SNP Genotyping Market, Competitive Intelligence, by Strategy, 2021-2024
Figure 35 : How a Strong ESG Proposition Benefits Businesses
Figure 36 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 37 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 46 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 47 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 48 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 49 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023